Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome

[1]  T. Miyazaki,et al.  Impaired alpha-interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromes. , 2009, Scandinavian journal of haematology.

[2]  J. Tschopp,et al.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.

[3]  S. Nagata,et al.  Purification and characterization of the Fas-ligand that induces apoptosis , 1994, The Journal of experimental medicine.

[4]  S. Jhanwar,et al.  Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. , 1992, Blood.

[5]  J. Whittaker,et al.  Clonal lymphocytes are detectable in only some cases of MDS , 1992, British journal of haematology.

[6]  M. Favre,et al.  CD45RA expression by CD4 T lymphocytes in tumors invaded by B‐cell non‐Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) , 1992, American journal of hematology.

[7]  V. Georgoulias,et al.  Immune function parameters at diagnosis in patients with myelodysplastic syndromes: Correlation with the FAB classification and prognosis , 1991, European journal of haematology.

[8]  C. Balch,et al.  Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. , 1990, Archives of surgery.

[9]  E. Engleman,et al.  Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. , 1990, Journal of immunology.

[10]  F. Mandelli,et al.  Deficiency of lymphocyte lectin-dependent cytotoxicity in myelodysplastic syndromes. , 1989, Acta haematologica.

[11]  A. Steinberg,et al.  Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. , 1988, The Journal of clinical investigation.

[12]  C. Balch,et al.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor , 1988, The Journal of experimental medicine.

[13]  G. Janossy,et al.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. , 1988, Journal of immunology.

[14]  N. Letvin,et al.  A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells , 1987, Nature.

[15]  V. Broudy,et al.  Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias. , 1987, Blood.

[16]  N. Letvin,et al.  A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. , 1987, The Journal of clinical investigation.

[17]  P. Greenberg.  Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. , 1986, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

[18]  M. Tomonaga,et al.  Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvenile chronic myeloid leukaemia: both granuloctye‐macrophage precursors and erythroid precursors carry identical marker chromosome , 1986, British journal of haematology.

[19]  Galton Da,et al.  Myelodysplastic syndromes: natural history and features of prognostic importance. , 1986, Clinics in haematology.

[20]  Koeffler Hp.  Myelodysplastic syndromes (preleukemia). , 1986 .

[21]  S. Rosenberg,et al.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. , 1986, Science.

[22]  R. Callard,et al.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. , 1986, Immunology.

[23]  G. Mufti,et al.  Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES , 1986, British journal of haematology.

[24]  T. Milson,et al.  Immunoregulatory abnormalities in myelodysplastic disorders , 1986, American journal of hematology.

[25]  J. Griffin,et al.  Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. , 1986, Blood.

[26]  A. Jacobs.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. , 1985, Journal of clinical pathology.

[27]  T. Economopoulos,et al.  Immune abnormalities in myelodysplastic syndromes. , 1985, Journal of clinical pathology.

[28]  N. Letvin,et al.  The isolation and characterization of the human helper inducer T cell subset. , 1985, Journal of immunology.

[29]  E. Engleman,et al.  Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. , 1983, Journal of immunology.

[30]  G. Trinchieri,et al.  A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. , 1983, Journal of immunology.

[31]  C. Scott,et al.  Decreased T helper cells in the myelodysplastic syndromes , 1983, British journal of haematology.

[32]  H. Heimpel,et al.  Impaired T-cell and NK-cell function in patients with preleukemia , 1982, Blut.

[33]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[34]  D. Wiley,et al.  Pillars Article: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. , 2005 .

[35]  P. Kluin,et al.  Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. , 1992, Blood.

[36]  E. Lotzová,et al.  Natural killer cells: definition, heterogeneity, lytic mechanism, functions and clinical application. Highlights of the Fifth International Workshop on natural killer cells, Hilton Head Island, N.C., March 1988. , 1989, Natural immunity and cell growth regulation.

[37]  H. Heimpel,et al.  Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. , 1989, Blood.

[38]  M. Sanders,et al.  Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. , 1988, Immunology today.

[39]  Y. Yoshida,et al.  Biology of myelodysplastic syndromes. , 1987, International journal of cell cloning.

[40]  P. Hokland,et al.  Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. , 1984, Leukemia research.

[41]  H. Heimpel,et al.  "Atypical" leukemias: preleukemia, smoldering leukemia and hypoplastic leukemia. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.